Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
about
In 2014, can we do better than CA125 in the early detection of ovarian cancer?Serum amyloid A: an acute-phase protein involved in tumour pathogenesisProteomics and mass spectrometry for cancer biomarker discoveryClinical proteomics and mass spectrometry profiling for cancer detection.Human body fluid proteome analysis.Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.Applications of SELDI-MS technology in oncologyIdentifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks.Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.Plasma biomarkers in a mouse model of preterm labor.Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsPhase II biomarker trial of a multimarker diagnostic for ovarian cancerQuantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoringThe new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivoIdentification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.Proteomic profiling identifies haptoglobin as a potential serum biomarker for steroid-resistant nephrotic syndrome.Protein biomarkers of ovarian cancer: the forest and the treesProteomic technology for biomarker profiling in cancer: an updateOvarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms.Time-of-flight mass spectrometry in screening serum-specific protein in patients with scrotal Paget's disease.Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Challenges for molecular profiling of chronic fatigue syndrome.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Dual effect of serum amyloid A on the invasiveness of glioma cells.Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rashMass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Ovarian cancer: biomarker proteomic diagnosis in progress.Plasma prefractionation methods for proteomic analysis and perspectives in clinical applications.Contrasting increased levels of serum amyloid A in patients with three different bone sarcomas: An indicator of tumor malignancy?SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.Exploring the expression bar code of SAA variants for gastric cancer detection.Serum amyloid a protein in clinical cancer diagnosis.Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker DiscoveryCreation of Individual Scientific Concept-Centered Semantic Maps Based on Automated Text-Mining Analysis of PubMed
P2860
Q26825152-F8330BA4-3F1F-4569-BC67-C50BFF99FDEEQ28291806-DCBA3EAE-CFE2-4016-8F0D-BFE3452D16FDQ28766969-55CC3957-A866-4143-B2E3-23DCFCF8E289Q33246668-731AD56D-E0D4-488D-9ED0-0224CC0A5669Q33262623-165E5282-3E4F-45BF-84D3-4B278BF5A030Q33301709-56270C87-AAF8-435B-91AF-D3ADB17BDC32Q33319301-5A50F0A5-9C39-4016-B4F3-89F6DFC8AA1EQ33322964-7DF6A4F3-1710-4D7A-AA08-48BFCEF928ACQ33338626-9CDA6544-B8A9-4FE6-9480-340B6699D9A5Q33344488-32018FAB-B391-47D6-B36C-D099995F00E2Q33418258-7DB6E0C1-C58D-4D5F-A3F2-9BF9AD50660EQ33584262-C56C4630-5BEC-44F3-AFA9-798A71274D62Q33868802-FDFC9103-B6D3-417F-96B5-D6716F83D4D0Q33945104-35DCBE7F-A1AC-4DA1-A565-FAA7012D2B01Q33990542-7E0BAB82-4592-455D-B77E-9D0FEDF90923Q34062814-EBA90F3B-AB4B-442E-B1EC-B701D154071CQ34097044-249E38B9-E4B3-4A95-AD52-4551E519256FQ34216967-57A9592F-2A1E-4BF7-8276-362FB5F123EAQ34324615-6659DEA0-B89E-46D1-BD89-8126C5978DFFQ34634143-30BF1E90-F001-4409-8AF2-096859494E09Q34657835-319AACFE-573C-4299-9208-021E3AD9554AQ34893763-356C391A-E35E-4D4D-865F-A060A112BF93Q34961484-5B72DF1B-2571-4B4C-9E36-A4B72D27C955Q35118218-73C8B02E-190F-436B-B9C6-BF7E43C189C2Q35995489-A8A5FC46-4C33-4FAD-A2AD-A22F68BCA65DQ36147848-339827BE-0826-4142-A6C0-1692423A6983Q36412667-69853518-2B61-4597-93C3-77C953D5704EQ36582422-BB96955A-9ABF-44E6-BB80-6A7E76DBEC64Q36682802-F3A73CCD-D3BA-4186-BC9A-92293D5D956CQ36686826-24F05B22-0FA0-4160-8178-69269C498A4CQ37340624-635218B9-9A88-45B6-8387-8DB91BCF7AABQ37484011-A473A52F-657A-4B17-A0E5-4F1C82E4999AQ38040333-5EDBD827-A5D0-423C-BE9F-01F646F252C2Q38947233-4DA66572-B546-453C-99B7-19CFF5FC5623Q43672699-A845A500-A5A8-47E8-85B9-6076492ED5AAQ44144829-8E6A05A7-9C66-4072-A43C-5BB367D5E07CQ48158874-1E40A246-D18F-488E-B77B-D2A03B321F14Q53282038-3085F62C-132E-4F3F-A229-E28778927428Q57173976-BD01FA52-A594-421C-AC69-65A6E3C34F86Q57174481-0D4386EE-CB02-4E05-97C9-153B757528B3
P2860
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
@ast
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
@en
type
label
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
@ast
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
@en
prefLabel
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
@ast
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
@en
P2093
P356
P1433
P1476
Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.
@en
P2093
Alexander I Archakov
Eugene I Goufman
Irina N Taranets
Oleg V Makarov
Olga V Tikhonova
Sergei A Moshkovskii
Victor G Zgoda
P304
P356
10.1002/PMIC.200401205
P577
2005-09-01T00:00:00Z